Artivion (AORT) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Artivion | 1.02 Bn | 961.00 Mn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.68% |
| Dec 31, 2025 | 58.02% |
| Sep 30, 2025 | 21.07% |
| Jun 30, 2025 | 19.52% |
| Mar 31, 2025 | 25.70% |
| Dec 31, 2024 | 4.34% |
| Sep 30, 2024 | 8.89% |
| Jun 30, 2024 | 13.38% |
| Mar 31, 2024 | 13.46% |
| Dec 31, 2023 | 19.26% |
| Sep 30, 2023 | 15.24% |
| Jun 30, 2023 | 16.07% |
| Mar 31, 2023 | 21.77% |
| Dec 31, 2022 | 20.02% |
| Sep 30, 2022 | 10.73% |
| Jun 30, 2022 | 7.97% |
| Mar 31, 2022 | 12.01% |
| Dec 31, 2021 | 13.62% |
| Sep 30, 2021 | 10.47% |
| Jun 30, 2021 | 7.75% |
| Mar 31, 2021 | 11.91% |
| Dec 31, 2020 | -18.95% |
| Sep 30, 2020 | 33.65% |
| Jun 30, 2020 | 4.26% |
| Mar 31, 2020 | 17.66% |
| Dec 31, 2019 | 25.94% |
| Sep 30, 2019 | 17.66% |
| Jun 30, 2019 | 21.27% |
| Mar 31, 2019 | 16.97% |
| Dec 31, 2018 | 13.18% |
| Sep 30, 2018 | 12.95% |
| Jun 30, 2018 | 17.80% |
| Mar 31, 2018 | 8.09% |
| Dec 31, 2017 | 6.82% |
| Sep 30, 2017 | 18.10% |
| Jun 30, 2017 | 20.35% |
| Mar 31, 2017 | 17.32% |
| Dec 31, 2016 | 14.38% |
| Sep 30, 2016 | 18.22% |
| Jun 30, 2016 | 14.93% |
| Mar 31, 2016 | 12.82% |
| Dec 31, 2015 | 6.76% |
| Sep 30, 2015 | 2.74% |